We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA Seeks Changes to FDA’s Draft Guidance on Dosage Labeling
PhRMA Seeks Changes to FDA’s Draft Guidance on Dosage Labeling
The Pharmaceutical Research and Manufacturers of America (PhRMA) is asking for several changes to the FDA’s January draft guidance on the dosage and administration section of labeling for drugs and biologics.